Wolverine Asset Management LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 10, 2022	BUY	$75.71 - $119.24 $688,961 - $1.09 Million	9,100 New	9,100 $1.01 Million
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $351,568 - $500,472	-2,800 Reduced 45.9%	3,300 $562,000
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $650,687 - $925,248	6,100 New	6,100 $727,000
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $540,200 - $822,700	-10,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $152,448 - $181,600	-3,200 Reduced 24.24%	10,000 $556,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $471,635 - $622,380	13,200	13,200 $598,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.